Annual Total Expenses
$164.06 M
+$59.48 M+56.88%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual total expenses is $164.06 million, with the most recent change of +$59.48 million (+56.88%) on December 31, 2021.
- During the last 3 years, ALBO annual total expenses has risen by +$113.43 million (+224.05%).
Performance
ALBO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Expenses
$44.49 M
-$920.00 K-2.03%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly total expenses is $44.49 million, with the most recent change of -$920.00 thousand (-2.03%) on September 30, 2022.
- Over the past year, ALBO quarterly total expenses has increased by +$1.64 million (+3.84%).
Performance
ALBO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ALBO Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +56.9% | +3.8% |
3 y3 years | +224.1% | +102.0% |
5 y5 years | +567.5% | +580.9% |
ALBO Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | -4.1% | -1.1% |
5 y | 5-year | at high | -56.9% | -4.1% | -63.4% |
alltime | all time | at high | -97.9% | -4.1% | -96.5% |
Albireo Pharma Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $44.49 M(-2.0%) |
Jun 2022 | - | $45.41 M(-2.1%) |
Mar 2022 | - | $46.39 M(+5.4%) |
Dec 2021 | $164.06 M(+56.9%) | $44.02 M(+2.7%) |
Sep 2021 | - | $42.84 M(+20.8%) |
Jun 2021 | - | $35.46 M(-15.1%) |
Mar 2021 | - | $41.74 M(+73.1%) |
Dec 2020 | $104.58 M(+47.8%) | $24.12 M(-17.5%) |
Sep 2020 | - | $29.23 M(+45.3%) |
Jun 2020 | - | $20.13 M(-35.3%) |
Mar 2020 | - | $31.10 M(+91.0%) |
Dec 2019 | $70.75 M(+39.7%) | $16.28 M(-26.1%) |
Sep 2019 | - | $22.02 M(+33.2%) |
Jun 2019 | - | $16.53 M(+3.8%) |
Mar 2019 | - | $15.92 M(+7.5%) |
Dec 2018 | $50.63 M(+106.0%) | $14.81 M(+14.8%) |
Sep 2018 | - | $12.90 M(+15.9%) |
Jun 2018 | - | $11.14 M(-5.5%) |
Mar 2018 | - | $11.78 M(+120.8%) |
Dec 2017 | $24.58 M(+3.9%) | $5.34 M(-18.3%) |
Sep 2017 | - | $6.53 M(-1.1%) |
Jun 2017 | - | $6.61 M(+8.4%) |
Mar 2017 | - | $6.10 M(+289.6%) |
Dec 2016 | $23.66 M(+69.3%) | - |
Sep 2016 | - | $1.56 M(-49.5%) |
Sep 2016 | $13.97 M(-29.3%) | - |
Jun 2016 | - | $3.10 M(-49.0%) |
Mar 2016 | - | $6.08 M(+88.5%) |
Dec 2015 | - | $3.23 M(-5.7%) |
Sep 2015 | $19.77 M(+2.6%) | $3.42 M(-48.0%) |
Jun 2015 | - | $6.58 M(+45.3%) |
Mar 2015 | - | $4.53 M(-13.6%) |
Dec 2014 | - | $5.24 M(+42.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2014 | $19.26 M(-6.5%) | $3.69 M(-22.3%) |
Jun 2014 | - | $4.75 M(-17.9%) |
Mar 2014 | - | $5.78 M(+14.7%) |
Dec 2013 | - | $5.04 M(+15.7%) |
Sep 2013 | $20.59 M(+6.7%) | $4.36 M(-16.5%) |
Jun 2013 | - | $5.22 M(+2.1%) |
Mar 2013 | - | $5.11 M(-13.5%) |
Dec 2012 | - | $5.91 M(+3.3%) |
Sep 2012 | $19.30 M(-16.9%) | $5.72 M(+20.9%) |
Jun 2012 | - | $4.73 M(+5.8%) |
Mar 2012 | - | $4.47 M(+2.3%) |
Dec 2011 | - | $4.37 M(-5.1%) |
Sep 2011 | $23.22 M(-37.5%) | $4.61 M(-13.4%) |
Jun 2011 | - | $5.32 M(+2.2%) |
Mar 2011 | - | $5.21 M(-35.6%) |
Dec 2010 | - | $8.08 M(+16.7%) |
Sep 2010 | $37.16 M(-14.2%) | $6.93 M(-20.1%) |
Jun 2010 | - | $8.67 M(-16.6%) |
Mar 2010 | - | $10.39 M(-7.0%) |
Dec 2009 | - | $11.17 M(+6.1%) |
Sep 2009 | $43.32 M(-8.5%) | $10.52 M(-1.5%) |
Jun 2009 | - | $10.68 M(-9.4%) |
Mar 2009 | - | $11.80 M(+14.3%) |
Dec 2008 | - | $10.32 M(-26.3%) |
Sep 2008 | $47.35 M(+94.7%) | $13.99 M(+26.7%) |
Jun 2008 | - | $11.04 M(+3.8%) |
Mar 2008 | - | $10.64 M(-8.9%) |
Dec 2007 | - | $11.68 M(+6.4%) |
Sep 2007 | $24.32 M(+222.8%) | $10.97 M(+161.3%) |
Jun 2007 | - | $4.20 M(-21.1%) |
Mar 2007 | - | $5.32 M(+37.9%) |
Dec 2006 | - | $3.86 M |
Sep 2006 | $7.54 M(+122.3%) | - |
Sep 2005 | $3.39 M | - |
FAQ
- What is Albireo Pharma annual total expenses?
- What is the all time high annual total expenses for Albireo Pharma?
- What is Albireo Pharma annual total expenses year-on-year change?
- What is Albireo Pharma quarterly total expenses?
- What is the all time high quarterly total expenses for Albireo Pharma?
- What is Albireo Pharma quarterly total expenses year-on-year change?
What is Albireo Pharma annual total expenses?
The current annual total expenses of ALBO is $164.06 M
What is the all time high annual total expenses for Albireo Pharma?
Albireo Pharma all-time high annual total expenses is $164.06 M
What is Albireo Pharma annual total expenses year-on-year change?
Over the past year, ALBO annual total expenses has changed by +$59.48 M (+56.88%)
What is Albireo Pharma quarterly total expenses?
The current quarterly total expenses of ALBO is $44.49 M
What is the all time high quarterly total expenses for Albireo Pharma?
Albireo Pharma all-time high quarterly total expenses is $46.39 M
What is Albireo Pharma quarterly total expenses year-on-year change?
Over the past year, ALBO quarterly total expenses has changed by +$1.64 M (+3.84%)